Skip to main content

김대식 교수

Dae Sik Kim

고려대학교 내과 · 의학

연구실 소개

김대식 교수의 연구실은 주로 신경영상학, 혈액행생물학, 감염병 및 자가면역질환 분야에서 임상적 정밀도를 높이기 위한 다학제적 연구를 수행하고 있습니다. 특히 뇌종양의 정확한 진단을 위한 영상진단 기법의 최적화, 다발성 골수종양의 예후 예측 지표 개발, 그리고 희귀 병원성 박테리아 및 자가면역성 혈소판감소성 출혈증 등의 병리 기전과 치료 전략 탐색이 핵심 연구 방향입니다. 최근에는 면역조절 기전을 타겟으로 한 신약 개발 및 생물학적 마커 기반 개인 맞춤 치료 전략 수립에도 주력하고 있습니다.

영상진단다발성 골수종양면역병리감염병개인 맞춤 치료

연구 현황

논문 수
124
총 인용 수
1,839
최근 5년 논문
32
주요 분야
의학

연구 성과 추이

표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.

5개년 연도별 논문 게재 수
32총합
2022
2023
2024
2025
2026
5개년 연도별 피인용 수
90총합
20222023202420252026

주요 논문

15
1
논문|인용수 164·2009
Distinguishing Tumefactive Demyelinating Lesions from Glioma or Central Nervous System Lymphoma: Added Value of Unenhanced CT Compared with Conventional Contrast-enhanced MR Imaging
Dae Sik Kim, Dong Gyu Na, Keon Ha Kim, Ji‐hoon Kim, Eunhee Kim, Bo La Yun, Kee‐Hyun Chang
SJR Q1Radiology

Unenhanced CT plus MR imaging was more accurate for distinguishing TDLs from glioma or CNS lymphoma than contrast-enhanced MR imaging alone.

GeneticsMedicine
2
논문|인용수 117·2009
Sonographic Features of Follicular Variant Papillary Thyroid Carcinomas in Comparison With Conventional Papillary Thyroid Carcinomas
Dae Sik Kim, Ji‐hoon Kim, Dong Gyu Na, Sung‐Hye Park, Eunhee Kim, K H Chang, Chul‐Ho Sohn, Young Ho Choi
SJR Q2Journal of Ultrasound in Medicine

Follicular variant papillary thyroid carcinomas show a relatively larger size, more benign sonographic features, a lower incidence of a sonographically malignant grade, and a lower diagnostic rate of PTC on FNAB compared with conventional PTCs.

Endocrinology, Diabetes and MetabolismMedicine
3
논문|인용수 33·2016
Myeloma prognostic index at diagnosis might be a prognostic marker in patients newly diagnosed with multiple myeloma
Dae Sik Kim, Eun Sang Yu, Ka‐Won Kang, Se Ryeon Lee, Yong Park, Hwa Jung Sung, Chul Won Choi, Byung Soo Kim
SJR Q2The Korean Journal of Internal MedicineOA

BACKGROUND/AIMS: The aims of this study were to identify the value of inflammatory markers as pretreatment prognostic factors for patients with multiple myeloma (MM) and to estimate the value of a prognostic index including these markers at diagnosis. METHODS: A total of 273 newly diagnosed MM patients undergoing active treatment were analyzed in this study. The prognostic values for survival of the pretreatment inflammatory markers were investigated. A myeloma prognostic index (MPI) was derived

HematologyMedicine
4
논문|인용수 20·2011
Bacteremia Caused by Laribacter hongkongensis Misidentified as Acinetobacter lwoffii: Report of the First Case in Korea
Dae Sik Kim, Yu Mi Wi, Ji Young Choi, Kyong Ran Peck, Jae‐Hoon Song, Kwan Soo Ko
SJR Q2Journal of Korean Medical ScienceOA

Laribacter hongkongensis is an emerging pathogen in patients with community-acquired gastroenteritis and traveler's diarrhea. We herein report a case of L. hongkongensis infection in a 24-yr-old male with liver cirrhosis complicated by Wilson's disease. He was admitted to a hospital with only abdominal distension. On day 6 following admission, he complained of abdominal pain and his body temperature reached 38.6℃. The results of peritoneal fluid evaluation revealed a leukocyte count of 1,180/µL

EpidemiologyMedicine
5
논문|인용수 18·2015
Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
Dae Sik Kim, Ka‐Won Kang, Se Ryeon Lee, Yong Park, Hwa Jung Sung, Seok Jin Kim, Chul Won Choi, Byung Soo Kim
SJR Q2Annals of Hematology
HematologyMedicine
6
리뷰|인용수 18·2022
Recent advances in treatments of adult immune thrombocytopenia
Dae Sik Kim
SJR Q2Blood ResearchOA

Immune thrombocytopenia (ITP) is isolated thrombocytopenia characterized by autoimmune-mediated disruption of platelet without other etiologies. Treatments for chronic ITP consist of corticosteroids, intravenous immunoglobulins, anti-D immunoglobulin, rituximab, thrombopoietin receptor agonists, immunosuppressants and splenectomy. Although current therapies are effective in over two-thirds of patients, some patients are refractory to therapies or fail to achieve long-term responses. Recently, gr

HematologyMedicine
7
논문|인용수 17·2017
Five factor score of more than 1 is associated with relapse during the first 2 year‐follow up in patients with eosinophilic granulomatosis with polyangiitis
Dae Sik Kim, Jason Jungsik Song, Yong‐Beom Park, Sang‐Won Lee
SJR Q3International Journal of Rheumatic DiseasesOA

AIM: We investigated what variables at diagnosis might be associated with the relapse of eosinophilic granulomatosis with polyangiitis (EGPA) and whether five factor score (FFS) at diagnosis might predict it. METHODS: We reviewed the medical records of 30 patients with EGPA having results of myeloperoxidase (MPO)-antineutrophil cytoplasmic antibodies (ANCA) and proteinase 3 (PR3)-ANCA and having achieved remission during the first therapeutic regimen administration within follow-up duration for

Pulmonary and Respiratory MedicineMedicine
8
논문|인용수 14·2014
Occurrence and Prognosis of Symptomatic Venous Thromboembolism in Colorectal Cancer Surgery Patients
Dae Sik Kim, Keun-Myoung Park, Yong Sung Won, Jang Yong Kim, Jin‐Kwon Lee, Jun Gi Kim, Seong Taek Oh, Sang Seol Jung, Won Kyung Kang
SJR Q3Vascular Specialist InternationalOA

Among CRC patients after surgery, the incidence of VTE was approximately 3% within 1 year and development of VTE wasn't a significant risk factor for death in our study but these findings are not conclusive due to our small sample size.

Internal MedicineMedicine
9
논문|인용수 12·2008
Association of Single Nucleotide Polymorphisms in PIM-1 Gene with the Risk of Korean Lung Cancer
Dae Sik Kim, Jae Sook Sung, Eun‐Soon Shin, Jeong‐Seon Ryu, In Keun Choi, Kyong Hwa Park, Yong Park, Eui Bae Kim, Seh Jong Park, Yeul Hong Kim
SJR Q1Cancer Research and TreatmentOA

The present results suggest that the T-C-T-C haplotype of the PIM-1 gene could influence the risk of developing smoking-related lung cancer in the Korean population. Additional functional studies with an larger sample sized analysis are warranted to reconfirm our findings.

Pathology and Forensic MedicineMedicine
10
논문|인용수 11·2014
Selection of Elderly Acute Myeloid Leukemia Patients for Intensive Chemotherapy: Effectiveness of Intensive Chemotherapy and Subgroup Analysis
Dae Sik Kim, Ka‐Won Kang, Eun Sang Yu, Hong Jun Kim, Jung Sun Kim, Se Ryeon Lee, Yong Park, Hwa Jung Sung, Soo Young Yoon, Chul Won Choi, Byung Soo Kim
SJR Q3Acta Haematologica

BACKGROUND: Despite the advances in acute myeloid leukemia (AML) treatment, the prognosis of elderly patients remains poor and no definitive treatment guideline has been established. In the present study, we aimed to evaluate the effectiveness of intensive chemotherapy in elderly AML patients and to determine which subgroup of patients would be most responsive to the therapy. METHODS: We retrospectively analyzed 84 elderly patients: 35, 19, and 30 patients were administered intensive chemotherap

HematologyMedicine
11
논문|인용수 11·2013
High-Dose Cytarabine Consolidation (≥1.5 g/m2) Might Have Shown a Better Outcomes Than Intermediate-Dose Cytarabine (1.0 g/m2) Combined With Anthracyclines In AML Patients Who Had Achieved Complete Remissions In The First Induction by Standard 3+7 Regimen
Yong Park, Ga-won Kang, Dae Sik Kim, Suk‐young Lee, Se Ryeon Lee, Hwa Jung Sung, Chul Won Choi, Seok Jin Kim, Myung‐Hyun Nam, Ji-Seon Choi, Soo‐Young Yoon, Byung Soo Kim
SJR Q1Blood

Abstract Purpose Based on CALGB trial in 1994, 3-4 cycles of high-dose cytarabine have been one of the standard consolidation therapies. Despite the confirmed efficacy of anthracyclines for remission induction, the role of anthracyclines for postremission consolidation is a subject still under debate. In this retrospective analysis, we compared the efficacy of high-dose cytarabine (>=1.5 g/m2) and intermediate-dose cytarabine (1 g/m2) combined with anthracyclines as postremission therapy. Met

HematologyMedicine
12
논문|인용수 10·2016
Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells
Dae Sik Kim, Yoo Jin Na, Myoung Hee Kang, Soo‐Young Yoon, Chul Won Choi
SJR Q2The Korean Journal of Internal MedicineOA

BACKGROUND/AIMS: The treatment of chronic myeloid leukemia (CML) has achieved impressive success since the development of the Bcr-Abl tyrosine kinase inhibitor, imatinib mesylate. Nevertheless, resistance to imatinib has been observed, and a substantial number of patients need alternative treatment strategies. METHODS: We have evaluated the effects of deferasirox, an orally active iron chelator, and imatinib on K562 and KU812 human CML cell lines. Imatinib-resistant CML cell lines were created b

HematologyMedicine
13
논문|인용수 6·2017
Loeffler endocarditis in chronic eosinophilic leukemia with FIP1L1/PDGFRA rearrangement: full recovery with low dose imatinib
Dae Sik Kim, Sunki Lee, Chul Won Choi
SJR Q2The Korean Journal of Internal MedicineOA
RheumatologyMedicine
14
논문|인용수 5·2007
Imaging and the Clinical-Pathologic Features of Invasive Micropapillary Carcinoma of the Breast
Dae Sik Kim, Nariya Cho, En Sook Ko, Do Youn Kim, Sang Kyu Yang, Seung Ja Kim, Woo Kyung Moon
Journal of the Korean Radiological SocietyOA

1993 Petersen , (1-3). , (1-8). (1) . . 1999 12 2005 5 3,109 . 25 3 . 22 48 ( 26-77).

DermatologyMedicine
15
논문|인용수 4·2014
Growth and Characterization of a Multi-dimensional ZnO Hybrid Structure on a Glass Substrate by using Metal Organic Chemical Vapor Deposition
김대식, Dohan Lee, Je-Haeng Lee, 변동진

A multi-dimensional zinc oxide (ZnO) hybrid structure was successfully grown on a glass substrateby using metal organic chemical vapor deposition (MOCVD). The ZnO hybrid structure wascomposed of nanorods grown continuously on the ZnO film without any catalysts. The growthmode could be changed from a two-dimensional (2D) film to one-dimensional (1D) nanorods bysimply controlling the substrate’s temperature. The ZnO with a hybrid structure showed improvedelectrical and optical properties. The ZnO

대표 연구 분야

HematologyPathology and Forensic MedicineOncologyPulmonary and Respiratory MedicineGeneticsMolecular Biology

김대식 교수의 연구를 Nubint에서 더 깊이 살펴보세요

이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.